What to Eat on GLP-1 Weight-Loss Drugs
Quick Facts
What should you eat while taking a GLP-1 weight-loss drug?
GLP-1 receptor agonists such as semaglutide and the dual GIP/GLP-1 medicine tirzepatide reduce appetite and delay gastric emptying. Because patients may feel full after eating much less than usual, each meal should provide meaningful nutrition. Practical choices include eggs, fish, poultry, beans, lentils, tofu, yogurt, vegetables, fruit and modest portions of whole grains, selected according to personal preferences and medical needs.
There is no single officially required GLP-1 diet. The US Food and Drug Administration prescribing information for Wegovy and Zepbound directs their use alongside a reduced-calorie diet and increased physical activity but does not prescribe a universal meal plan. A registered dietitian can personalize food intake for people with diabetes, kidney disease, gastrointestinal conditions, food insecurity or other needs that make generic diet advice inappropriate.
How can food choices reduce nausea and other digestive side effects?
Nausea, vomiting, diarrhea, constipation and abdominal discomfort are recognized adverse effects of semaglutide and tirzepatide. Symptoms may be more noticeable after treatment begins or the dose increases. Eating slowly, stopping at the first sign of fullness and avoiding very large meals can reduce the discomfort caused by adding food to a stomach that is emptying more slowly.
Greasy, fried or very rich foods worsen nausea for some patients, while bland foods may be easier to tolerate temporarily. Fluids should be taken regularly, particularly when vomiting or diarrhea occurs, but patients who become unable to keep liquids down should contact a clinician. Severe, persistent abdominal pain—with or without vomiting—needs prompt assessment because product labels warn about serious complications including acute pancreatitis and gallbladder disease.
How can patients protect muscle and prevent nutritional deficiencies?
Weight loss can involve both fat and lean tissue, regardless of whether it is achieved through medication, dietary change or surgery. Regular protein-containing meals and resistance exercise are therefore important considerations during GLP-1 treatment. Protein requirements vary with body size, age, activity, kidney function and other health factors, so a personalized target is safer than a universal high-protein prescription.
Patients should tell their clinician if appetite suppression makes it difficult to eat balanced meals or if they develop weakness, dizziness, persistent fatigue or repeated gastrointestinal symptoms. Supplements should address an identified need rather than replace food automatically. People using insulin or a sulfonylurea also need individualized diabetes guidance because combining these medicines with incretin-based treatment can increase the risk of hypoglycemia.
Frequently Asked Questions
No food is universally prohibited, but large, fatty or fried meals may worsen nausea and fullness. Follow any additional restrictions required for diabetes, kidney disease, allergies or another medical condition.
Contact a clinician for persistent vomiting, inability to keep fluids down, signs of dehydration or ongoing severe symptoms. Seek prompt medical assessment for severe abdominal pain, especially when it persists or is accompanied by vomiting.
Protein can help support lean tissue, but the appropriate amount differs between patients. People with kidney disease or other complex conditions should obtain an individualized recommendation from their clinician or dietitian.
References
- US Food and Drug Administration. Wegovy (semaglutide) prescribing information.
- US Food and Drug Administration. Zepbound (tirzepatide) prescribing information.
- Newsweek. Pharmacists Warn About Diet on Weight Loss Drugs – Here’s What To Eat. 2026.